Simris Alg publishes its annual report for 2021

Simris Alg AB has published its annual report for the 2021 financial year.

The annual report for 2021 is available to download on the company's website www.simrisalg.se/investerare. The Annual General Meeting will be held on Friday, May 25, 2022.

For further information, please contact:

Steven Schapera, chairman, Simris Alg AB

Tel: +44 791 771 5533, email: steven@simris.com

About Simris Alg

Simris Alg is a pioneering biotechnology company dedicated to the enormous potential of microalgae in the discovery and production of high-quality bioactive substances and alternatives to unsustainable marine ingredients. We are engaged in research, development, and production of bioactive substances from microalgae, for nutraceutical, cosmetic and pharmaceutical applications. Our technology provides access to bioactive substances with new functions, while at the same time replacing unsustainable raw materials from endangered marine species and ecosystems.

Simris Alg’s share is traded on Nasdaq First North Growth Market with the ticker SIMRIS and ISIN-code SE0008091664. Mangold Fondkommission AB is the Company’s Certified Adviser, reachable by tel: 08-503 015 50 and email: ca@mangold.se.